Recently, Kato et al [43] reported that SARS-CoV-2 induced the production of mucin (MUC)5AC and MUC5B throughout all airway regions via epidermal growth factor receptor/interleukin-1 receptor signaling activation in patients with COVID-19 [43]. This evidence concerns the gene EGFR and COVID-19.